RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine.

Park L, Furey M, Nugent A, Farmer C, Ellis J, Szczepanik J, Lener M, Zarate C

Open source

DOI
10.1016/j.biopsych.2018.02.787
Published
2018 May 1
Container
Biological psychiatry
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopsych.2018.02.787,
  title = {RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine.},
  author = {Park L and Furey M and Nugent A and Farmer C and Ellis J and Szczepanik J and Lener M and Zarate C},
  year = {2018},
  journal = {Biological psychiatry},
  doi = {10.1016/j.biopsych.2018.02.787},
  url = {https://doi.org/10.1016/j.biopsych.2018.02.787}
}

RIS

TY  - JOUR
TI  - RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine.
AU  - Park L
AU  - Furey M
AU  - Nugent A
AU  - Farmer C
AU  - Ellis J
AU  - Szczepanik J
AU  - Lener M
AU  - Zarate C
PY  - 2018
JO  - Biological psychiatry
DO  - 10.1016/j.biopsych.2018.02.787
UR  - https://doi.org/10.1016/j.biopsych.2018.02.787
ER  - 

APA

L, P., M, F., A, N., C, F., J, E., J, S., M, L., & C, Z. (2018). RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine.. Biological psychiatry. https://doi.org/10.1016/j.biopsych.2018.02.787

Source records